Extracellular RNA mediates and marks cancer progression

Seminars in Cancer Biology

Volumn 28, Issue , 2014, Pages 14-23

  Redzic, Jasmina S ^a   Balaj, Leonora ^b   van der Vos, Kristan E ^b,c   Breakefield, Xandra O ^b  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c NETHERLANDS CANCER INSTITUTE   (Netherlands)

Author keywords

Cancer; Extracellular vesicles; RNA

Indexed keywords

MESSENGER RNA; MICRORNA; UNTRANSLATED RNA; RNA; TUMOR MARKER;

BREAST CANCER; CANCER GROWTH; CANCER SURVIVAL; CARCINOGENESIS; CELL COMMUNICATION; CELL MEMBRANE; CELL MIGRATION; CELL PROLIFERATION; COLON CANCER; CYTOPLASM; DISEASE MARKER; DOWN REGULATION; ENDOCYTOSIS; GENE EXPRESSION; GENE FUNCTION; GLIOBLASTOMA; GROWTH INHIBITION; HISTONE MODIFICATION; HUMAN; LEUKOCYTE COUNT; PANCREAS CANCER; PHAGOCYTOSIS; PINOCYTOSIS; PROSTATE CANCER; PROTEIN AGGREGATION; REVIEW; RNA TRANSPORT; STOMACH CANCER; TUMOR GROWTH; UNTRANSLATED REGION; ANIMAL; DISEASE COURSE; METABOLISM; NEOPLASM; PATHOLOGY; PHYSIOLOGY;

ANIMALS; BIOMARKERS, TUMOR; CELL COMMUNICATION; DISEASE PROGRESSION; NEOPLASMS; RNA;

EID: 84926252899     PISSN: 1044579X     EISSN: 10963650     Source Type: Journal    
DOI: 10.1016/j.semcancer.2014.04.010     Document Type: Review

References (147)

1. Kolodny G.M. Evidence for transfer of macromolecular RNA between mammalian cells in culture. Exp Cell Res 1971, 65:313-324.
2. Valadi H., Ekström K., Bossios A., Sjöstrand M., Lee J.J., Lötvall J.O. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol 2007, 9:654-659.
3. Skog J., Würdinger T., van Rijn S., Meijer D., Gainche L., Curry W.T.J., et al. Glioblastoma microvesicles transport RNA and protein that promote tumor growth and provide diagnostic biomarkers. Nat Cell Biol 2008, 10:1470-1476.
4. Baj-Krzyworzeka M., Szatanek R., Weglarczyk K., Baran J., Urbanowicz B., Branski P., et al. Tumour-derived microvesicles carry several surface determinants and mRNA of tumour cells and transfer some of these determinants to monocytes. Cancer Immunol Immunother 2006, 55:808-818.
5. Panagopoulos K., Cross-Knorr S., Dillard C., Pantazatos D., Del Tatto M., Mills D., et al. Reversal of chemosensitivity and induction of cell malignancy of a non-malignant prostate cancer cell line upon extracellular vesicle exposure. Mol Cancer 2013, 12:118.
6. Renzulli J.F., Del Tatto M., Dooner G., Aliotta J., Goldstein L., Dooner M., et al. Microvesicle induction of prostate specific gene expression in normal human bone marrow cells. J Urol 2010, 184:2165-2171.
7. Rak J. Microparticles in cancer. Semin Thromb Hemost 2010, 36:888-906.
8. Al-Nedawi K., Meehan B., Micallef J., Lhotak V., May L., Guha A., et al. Intercellular transfer of the oncogenic receptor EGFRvIII by microvesicles derived from tumour cells. Nat Cell Biol 2008, 10:619-624.
9. Peinado H., Alečković M., Lavotshkin S., Matei I., Costa-Silva B., Moreno-Bueno G., et al. Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET. Nat Med 2012, 18:883-891.
10. Etheridge A., Gomes C.P., Pereira R.W., Galas D., Wang K. The complexity, function and applications of RNA in circulation. Front Genet 2013, 4:115.
11. Vickers K.C., Palmisano B.T., Shoucri B.M., Shamburek R.D., Remaley A.T. MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins. Nat Cell Biol 2011, 13:423-433.
12. Arroyo J.D., Chevillet J.R., Kroh E.M., Ruf I.K., Pritchard C.C., Gibson D.F., et al. Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma. Proc Natl Acad Sci U S A 2011, 108:5003-5008.
13. Chen X., Liang H., Zhang J., Zen K., Zhang C.Y. Secreted microRNAs: a new form of intercellular communication. Trends Cell Biol 2012, 22:125-132.
14. Camussi G., Deregibus M.C., Bruno S., Cantaluppi V., Biancone L. Exosomes/microvesicles as a mechanism of cell-to-cell communication. Kidney Int 2010, 78:838-848.
15. Castellana D., Toti F., Freyssinet J.M. Membrane microvesicles: macromessengers in cancer disease and progression. Thromb Res 2010, 125:S84-S88.
16. Logozzi M., De Milito A., Lugini L., Borghi M., Calabrò L., Spada M., et al. High levels of exosomes expressing CD63 and caveolin-1 in plasma of melanoma patients. PLoS ONE 2009, 4:e5219.
17. Chen C., Skog J., Hsu C-H., Lessard R., Breakefield X.O., Toner M., et al. Microfluidic isolation and transcriptome analysis of serum microvesicles. Lab Chip 2010, 5:505-511.
18. Keller S., König A.K., Marmé F., Runz S., Wolterink S., Koensgen D., et al. Systemic presence and tumor-growth promoting effect of ovarian carcinoma released exosomes. Cancer Lett 2009, 278:73-81.
19. Pisitkun T., Shen R.F., Knepper M.A. Identification and proteomic profiling of exosomes in human urine. Proc Natl Acad Sci U S A 2004, 101:13368-13373.
20. Inal J.M., Ansa-Addo E.A., Stratton D., Kholia S., Antwi-Baffour S.S., Jorfi S., et al. Microvesicles in health and disease. Arch Immunol Ther Exp 2012, 60:107-121.
21. Balaj L., Lessard R., Dai L., Cho Y-J., Pomeroy S.L., Breakefield X.O., et al. Tumour microvesicles contain retrotransposon elements and amplified oncogene sequences. Nat Commun 2011, 2:180.
22. Filipazzi P., Burdek M., Villa A., Rivoltini L., Huber V., Filipazzi P., et al. Recent advances on the role of tumor exosomes in immunosuppression and disease progression. Semin Cancer Biol 2012, 22:342-349.
23. Théry C., Ostrowski M., Segura E. Membrane vesicles as conveyors of immune responses. Nat Rev Immunol 2009, 9:581-593.
24. Hulsmans M., Holvoet P. MicroRNA-containing microvesicles regulating inflammation in association with atherosclerotic disease. Cardiovasc Res 2013, 100:7-18.
25. Meckes D.G.J., Shair K.H., Marquitz A.R., Kung C.P., Edwards R.H., Raab-Traub N. Human tumor virus utilizes exosomes for intercellular communication. Proc Natl Acad Sci U S A 2010, 107:20370-20375.
26. Simons M., Raposo G. Exosomes - vesicular carriers for intercellular communication. Curr Opin Cell Biol 2009, 21:575-581.
27. Bellingham S.A., Guo B.B., Coleman B.M., Hill A.F. Exosomes: vehicles for the transfer of toxic proteins associated with neurodegenerative diseases?. Front Physiol 2012, 3:124.
28. Baj-Krzyworzeka M., Szatanek R., Weglarczyk K., Baran J., Zembala M. Tumour-derived microvesicles modulate biological activity of human monocytes. Immunol Lett 2007, 113:76-82.
29. Al-Nedawi K., Meehan B., Kerbel R.S., Allison A.C., Rak J. Endothelial expression of autocrine VEGF upon the uptake of tumor-derived microvesicles containing oncogenic EGFR. Proc Natl Acad Sci U S A 2009, 106:3794-3799.
30. Kahlert C., Kalluri R. Exosomes in tumor microenvironment influence cancer progression and metastasis. J Mol Med (Berl) 2013, 91:431-437.
31. Pap E., Pallinger E., Falus A. The role of membrane vesicles in tumorigenesis. Crit Rev Oncol Hematol 2011, 79:213-223.
32. Antonyak M.A., Li B., Boroughs L.K., Johnson J.L., Druso J.E., Bryant K.L., et al. Cancer cell-derived microvesicles induce transformation by transferring tissue transglutaminase and fibronectin to recipient cells. Proc Natl Acad Sci U S A 2011, 108:4852-4857.
33. Valenti R., Huber V., Iero M., Filipazzi P., Parmiani G., Rivoltini L. Tumor-released microvesicles as vehicles of immunosuppression. Cancer Res 2007, 67:2912-2915.
34. Iero M., Valenti R., Huber V., Filipazzi P., Parmiani G., Fais S., et al. Tumour-released exosomes and their implications in cancer immunity. Cell Death Differ 2008, 15:80-88.
35. Cocucci E., Racchetti G., Meldolesi J. Shedding microvesicles: artefacts no more. Trends Cell Biol 2009, 19:43-51.
36. Gould S.J., Raposo G. As we wait: coping with an imperfect nomenclature for extracellular vesicles. J Extracell Ves 2013, 2:20389.
37. György B., Szabó T.G., Pásztói M., Pál Z., Misják P., Aradi B., et al. Membrane vesicles, current state-of-the-art: emerging role of extracellular vesicles. Cell Mol Life Sci 2011, 68:2667-2688.
38. Mathivanan S., Ji H., Simpson R.J. Exosomes: extracellular organelles important in intercellular communication. J Proteomics 2010, 73:1907-1920.
39. Théry C., Zitvogel L., Amigorena S. Exosomes: composition, biogenesis and function. Nat Rev Immunol 2002, 2:569-579.
40. Keller S., Sanderson M.P., Stoeck A., Altevogt P. Exosomes: from biogenesis and secretion to biological function. Immunol Lett 2006, 107:102-108.
41. Di Vizio D., Morello M., Dudley A.C., Schow P.W., Adam R.M., Morley S., et al. Large oncosomes in human prostate cancer tissues and in the circulation of mice with metastatic disease. Am J Pathol 2012, 181:1573-1584.
42. Mathivanan S., Fahner C.J., Reid G.E., Simpson R.J. ExoCarta 2012: database of exosomal proteins, RNA and lipids. Nucleic Acids Res 2012, 40:D1241-D1244.
43. Noerholm M., Balaj L., Limperg T., Salehi A., Zhu L.D., Hochberg F.H., et al. RNA expression patterns in serum microvesicles from patients with glioblastoma multiforme and controls. BMC Cancer 2012, 12:22.
44. Lee Y., El Andaloussi S., Wood M.J. Exosomes and microvesicles: extracellular vesicles for genetic information transfer and gene therapy. Hum Mol Genet 2012, 21:R125-R134.
45. Raposo G., Stoorvogel W. Extracellular vesicles: exosomes, microvesicles, and friends. J Cell Biol 2013, 200:373-383.
46. Rabinowits G., Gerçel-Taylor C., Day J.M., Taylor D.D., Kloecker G.H. Exosomal microRNA: a diagnostic marker for lung cancer. Clin Lung Cancer 2009, 10:42-46.
47. Bellingham S.A., Coleman B.M., Hill A.F. Small RNA deep sequencing reveals a distinct miRNA signature released in exosomes from prion-infected neuronal cells. Nucleic Acids Res 2012, 40:10937-10949.
48. Taylor D.D., Gercel-Taylor C. MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer. Gynecol Oncol 2008, 110:13-21.
49. Huang X., Yuan T., Tschannen M., Sun Z., Jacob H., Du M., et al. Characterization of human plasma-derived exosomal RNAs by deep sequencing. BMC Genomics 2013, 14:319.
50. Li C.C., Eaton S.A., Young P.E., Lee M., Shuttleworth R., Humphreys D.T., et al. Glioma microvesicles carry selectively packaged coding and non-coding RNAs which alter gene expression in recipient cells. RNA Biol 2013, 10:1333-1344.
51. Ratajczak J., Miekus K., Kucia M., Zhang J., Reca R., Dvorak P., et al. Embryonic stem cell-derived microvesicles reprogram hematopoietic progenitors: evidence for horizontal transfer of mRNA and protein delivery. Leukemia 2006, 20:847-856.
52. Zhang Y., Liu D., Chen X., Li J., Li L., Bian Z., et al. Secreted monocytic miR-150 enhances targeted endothelial cell migration. Mol Cell 2010, 39:133-144.
53. Yang M., Chen J., Su F., Yu B., Su F., Lin L., et al. Microvesicles secreted by macrophages shuttle invasion-potentiating microRNAs into breast cancer cells. Mol Cancer 2011, 10:117.
54. Villarroya-Beltri C., Gutiérrez-Vázquez C., Sánchez-Madrid F., Mittelbrunn M. Analysis of microRNA and protein transfer by exosomes during an immune synapse. Methods Mol Biol 2013, 1024:41-51.
55. Lopez-Verrilli M.A., Court F.A. Exosomes: mediators of communication in eukaryotes. Biol Res 2013, 46:5-11.
56. Muralidharan-Chari V., Clancy J.W., Sedgwick A., D'Souza-Schorey C. Microvesicles: mediators of extracellular communication during cancer progression. J Cell Sci 2010, 123:1603-1611.
57. van Kilsdonk J.W., van Kempen L.C., van Muijen G.N., Ruiter D.J., Swart G.W. Soluble adhesion molecules in human cancers: sources and fates. Eur J Cell Biol 2010, 89:415-427.
58. Svensson K.J., Christianson H.C., Wittrup A., Bourseau-Guilmain E., Lindqvist E., Svensson L.M., et al. Exosome uptake depends on ERK1/2-heat shock protein 27 signaling and lipid Raft-mediated endocytosis negatively regulated by caveolin-1. J Biol Chem 2013, 288:17713-17724.
59. Nolte-'t Hoen E.N., Buermans H.P., Waasdorp M., Stoorvogel W., Wauben M.H., 't Hoen P.A. Deep sequencing of RNA from immune cell-derived vesicles uncovers the selective incorporation of small non-coding RNA biotypes with potential regulatory functions. Nucleic Acids Res 2012, 40:9272-9285.
60. Taylor D.D., Gercel-Taylor C. The origin, function, and diagnostic potential of RNA within extracellular vesicles present in human biological fluids. Front Genet 2013, 4:142.
61. Grossman S.A., Ye X., Lesser G., Sloan A., Carraway H., Desideri S., et al. Immunosuppression in patients with high-grade gliomas treated with radiation and temozolomide. Clin Cancer Res 2011, 17:5473-5480.
62. van der Vos K.E., Balaj L., Skog J., Breakefield X.O. Brain tumor microvesicles: insights into intercellular communication in the nervous system. Cell Mol Neurobiol 2011, 31:949-959.
63. Collino F., Deregibus M.C., Bruno S., Sterpone L., Aghemo G., Viltono L., et al. Microvesicles derived from adult human bone marrow and tissue specific mesenchymal stem cells shuttle selected pattern of miRNAs. PLoS ONE 2010, 5:e11803.
64. Bolukbasi M.F., Mizrak A., Ozdener B.G., Madlener S., Ströbel T., Skog J., et al. miR-1289 and zipcode-like sequence enrich mRNAs in microvesicles. Mol Ther Nucl Acids 2012, 1:e10. 10.1038/mtna.2011.2.
65. Villarroya-Beltri C., Gutiérrez-Vázquez C., Sánchez-Cabo F., Pérez-Hernández D., Vázquez J., Sánchez-Madrid F., et al. Sumoylated hnRNPA2B1 controls the sorting of miRNAs into exosomes through binding to specific motifs. Nat Commun 2013, 4:2980.
66. Bartel D.P. MicroRNAs: target recognition and regulatory functions. Cell 2009, 136:215-233.
67. Liang H., Gong F., Zhang S., Zhang C.Y., Zen K., Chen X. The origin, function, and diagnostic potential of extracellular microRNAs in human body fluids. Wiley Interdiscip Rev RNA 2014, 5:285-300.
68. Simpson R.J., Kalra H., Mathivanan S. ExoCarta as a resource for exosomal research. J Extracell Ves 2012, 1. doi: 10.3402/jev.v1i0.18374.
69. Guduric-Fuchs J., O'Connor A., Camp B., O'Neill C.L., Medina R.J., Simpson D.A. Selective extracellular vesicle-mediated export of an overlapping set of microRNAs from multiple cell types. BMC Genomics 2012, 13:357.
70. Mittelbrunn M., Gutiérrez-Vázquez C., Villarroya-Beltri C., González S., Sánchez-Cabo F., González M.Á., et al. Unidirectional transfer of microRNA-loaded exosomes from T cells to antigen-presenting cells. Nat Commun 2011, 2:282.
71. Zernecke A., Bidzhekov K., Noels H., Shagdarsuren E., Gan L., Denecke B., et al. Delivery of microRNA-126 by apoptotic bodies induces CXCL12-dependent vascular protection. Sci Signal 2009, 2:ra81.
72. Pegtel D.M., Cosmopoulos K., Thorley-Lawson D.A., van Eijndhoven M.A., Hopmans E., Lindengey J.L., et al. Functional delivery of viral miRNAs via exosomes. Proc Natl Acad Sci U S A 2010, 107:6328-6333.
73. Fabbri M., Paone A., Calore F., Galli R., Gaudio E., Santhanam R., et al. MicroRNAs bind to Toll-like receptors to induce prometastatic inflammatory response. Proc Natl Acad Sci U S A 2012, 109:E2110-E2116.
74. Mizoguchi M., Guan Y., Yoshimoto K., Hata N., Amano T., Nakamizo A., et al. Clinical implications of microRNAs in human glioblastoma. Front Oncol 2013, 3:19.
75. Bader A.G. miR-34 - a microRNA replacement therapy is headed to the clinic. Front Genet 2012, 3(120). 10.3389/fgene.2012.00120.
76. Deregibus M.C., Cantaluppi V., Calogero R., Lo Iacono M., Tetta C., Biancone L., et al. Endothelial progenitor cell derived microvesicles activate an angiogenic program in endothelial cells by a horizontal transfer of mRNA. Blood 2007, 110:2440-2448.
77. Sharma S., Kelly T.K., Jones P.A. Epigenetics in cancer. Carcinogenesis 2010, 31:27-36.
78. Patil V.S., Zhou R., Rana T.M. Gene regulation by non-coding RNAs. Crit Rev Biochem Mol Biol 2014, 49:16-32.
79. Esteller M. Non-coding RNAs in human disease. Nat Rev Genet 2011, 12:861-874.
80. Hu S., Wu J., Chen L., Shan G. Signals from noncoding RNAs: unconventional roles for conventional pol III transcripts. Int J Biochem Cell Biol 2012, 44:1847-1851.
81. Cheng J., Guo J.M., Xiao B.X., Miao Y., Jiang Z., Zhou H., et al. piRNA, the new non-coding RNA, is aberrantly expressed in human cancer cells. Clin Chim Acta 2011, 412:1621-1625.
82. Calin G.A., Liu C.G., Ferracin M., Hyslop T., Spizzo R., Sevignani C., et al. Ultraconserved regions encoding ncRNAs are altered in human leukemias and carcinomas. Cancer Cell 2007, 12:215-229.
83. Fabbri M., Garzon R., Cimmino A., Liu Z., Zanesi N., Callegari E., et al. MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3B. Proc Natl Acad Sci U S A 2007, 104:15805-15810.
84. Garzon R., Liu S., Fabbri M., Liu Z., Heaphy C.E., Callegari E., et al. MicroRNA-29b induces global DNA hypomethylation and tumor suppressor gene reexpression in acute myeloid leukemia by targeting directly DNMT3A and 3B and indirectly DNMT1. Blood 2009, 113:6411-6418.
85. Suzuki H., Maruyama R., Yamamoto E., Kai M. DNA methylation and microRNA dysregulation in cancer. Mol Oncol 2012, 6:567-578.
86. Gal-Yam E.N., Egger G., Iniguez L., Holster H., Einarsson S., Zhang X., et al. Frequent switching of Polycomb repressive marks and DNA hypermethylation in the PC3 prostate cancer cell line. Proc Natl Acad Sci U S A 2008, 105:12979-12984.
87. Fraga M.F., Esteller M. Towards the human cancer epigenome: a first draft of histone modifications. Cell Cycle 2005, 4:1377-1381.
88. Friedman J.M., Liang G., Liu C.C., Wolff E.M., Tsai Y.C., Ye W., et al. The putative tumor suppressor microRNA-101 modulates the cancer epigenome by repressing the polycomb group protein EZH2. Cancer Res 2009, 69:2623-2629.
89. Dinger M.E., Mercer T.R., Mattick J.S. RNAs as extracellular signaling molecules. J Mol Endocrinol 2008, 40:151-159.
90. Goodier J.L., Kazazian H.H.J. Retrotransposons revisited: the restraint and rehabilitation of parasites. Cell 2008, 135:23-35.
91. Daskalos A., Nikolaidis G., Xinarianos G., Savvari P., Cassidy A., Zakopoulou R., et al. Hypomethylation of retrotransposable elements correlates with genomic instability in non-small cell lung cancer. Int J Cancer 2009, 124:81-87.
92. Ruprecht K., Mayer J., Sauter M., Roemer K., Mueller-Lantzsch N. Endogenous retroviruses and cancer. Cell Mol Life Sci 2008, 65:3366-3382.
93. Wang-Johanning F., Frost A.R., Jian B., Epp L., Lu D.W., Johanning G.L. Quantitation of HERV-K env gene expression and splicing in human breast cancer. Oncogene 2003, 22:1528-1535.
94. Muster T., Waltenberger A., Grassauer A., Hirschl S., Caucig P., Romirer I., et al. An endogenous retrovirus derived from human melanoma cells. Cancer Res 2003, 63:8735-8741.
95. Contreras-Galindo R., Kaplan M.H., Leissner P., Verjat T., Ferlenghi I., Bagnoli F., et al. Human endogenous retrovirus K (HML-2) elements in the plasma of people with lymphoma and breast cancer. J Virol 2008, 82:9329-9336.
96. Baran J., Baj-Krzyworzeka M., Weglarczyk K., Szatanek R., Zembala M., Barbasz J., et al. Circulating tumour-derived microvesicles in plasma of gastric cancer patients. Cancer Immunol Immunother 2010, 59:841-850.
97. Silva J., Garcia V., Rodriguez M., Compte M., Cisneros E., Veguillas P., et al. Analysis of exosome release and its prognostic value in human colorectal cancer. Genes Chromosomes Cancer 2012, 51:409-418.
98. Millimaggi D., Mari M., D'Ascenzo S., Carosa E., Jannini E.A., Zucker S., et al. Tumor vesicle-associated CD147 modulates the angiogenic capability of endothelial cells. Neoplasia 2007, 9:349-357.
99. Delves G.H., Stewart A.B., Cooper A.J., Lwaleed B.A. Prostasomes, angiogenesis, and tissue factor. Semin Thromb Hemost 2007, 33:75-79.
100. Zhuang G., Wu X., Jiang Z., Kasman I., Yao J., Guan Y., et al. Tumour-secreted miR-9 promotes endothelial cell migration and angiogenesis by activating the JAK-STAT pathway. EMBO J 2012, 31:3513-3523.
101. Würdinger T., Tannous B.A., Saydam O., Skog J., Grau S., Soutschek J., et al. miR-296 regulates growth factor receptor overexpression in angiogenic endothelial cells. Cancer Cell 2008, 14:382-393.
102. Street J.M., Barran P.E., Mackay C.L., Weidt S., Balmforth C., Walsh T.S., et al. Identification and proteomic profiling of exosomes in human cerebrospinal fluid. J Transl Med 2012, 10:5.
103. Miranda K.C., Bond D.T., McKee M., Skog J., Păunescu T.G., Da Silva N., et al. Nucleic acids within urinary exosomes/microvesicles are potential biomarkers for renal disease. Kidney Int 2010, 78:191-199.
104. Lässer C., Alikhani V.S., Ekström K., Eldh M., Paredes P.T., Bossios A., et al. Human saliva, plasma and breast milk exosomes contain RNA: uptake by macrophages. J Transl Med 2011, 9:9.
105. Yen K.E., Bittinger M.A., Su S.M., Fantin V.R. Cancer-associated IDH mutations: biomarker and therapeutic opportunities. Oncogene 2010, 29:6409-6417.
106. Rak J. Extracellular vesicles - biomarkers and effectors of the cellular interactome in cancer. Front Pharmacol 2013, 4:21.
107. Nilsson J., Skog J., Nordstrand A., Baranov V., Mincheva-Nilsson L., Breakefield X.O., et al. Prostate cancer-derived urine exosomes: a novel approach to biomarkers for prostate cancer. Br J Cancer 2009, 100:1603-1607.
108. Kim H.K., Song K.S., Park Y.S., Kang Y.H., Lee Y.J., Lee K.R., et al. Elevated levels of circulating platelet microparticles, VEGF, IL-6 and RANTES in patients with gastric cancer: possible role of a metastasis predictor. Eur J Cancer 2003, 39:184-191.
109. García J.M., García V., Peña C., Domínguez G., Silva J., Diaz R., et al. Extracellular plasma RNA from colon cancer patients is confined in a vesicle-like structure and is mRNA-enriched. RNA 2008, 14:1424-1432.
110. Zhang L., Xiao H., Karlan S., Zhou H., Gross J., Elashoff D., et al. Discovery and preclinical validation of salivary transcriptomic and proteomic biomarkers for the non-invasive detection of breast cancer. PLoS ONE 2010, 5:e15573.
111. Zhang L., Farrell J.J., Zhou H., Elashoff D., Akin D., Park N.H., et al. Salivary transcriptomic biomarkers for detection of resectable pancreatic cancer. Gastroenterology 2010, 138:949-957.
112. Lee Y.H., Kim J.H., Zhou H., Kim B.W., Wong D.T. Salivary transcriptomic biomarkers for detection of ovarian cancer: for serous papillary adenocarcinoma. J Mol Med 2012, 90:427-434.
113. Wang F., Xu Z., Zhou J., Lo W.S., Lau C.F., Nangle L.A., et al. Regulated capture by exosomes of mRNAs for cytoplasmic tRNA synthetases. J Biol Chem 2013, 288:29223-29228.
114. Johnson H., Del Rosario A.M., Bryson B.D., Schroeder M.A., Sarkaria J.N., White F.M. Molecular characterization of EGFR and EGFRvIII signaling networks in human glioblastoma tumor xenografts. Mol Cell Proteomics 2012, 11:1724-1740.
115. Chen W.W., Balaj L., Liau L.M., Samuels M., Kotsopoulos S., Maguire C.A., et al. BEAMing and digital droplet of qRT-PCR analysis of mutant IDH1 mRNA in tumor extracellular vesicles. Mol Ther Nucl Acids 2013, 2:e109.
116. Borodovsky A., Seltzer M.J., Riggins G.J. Altered cancer cell metabolism in gliomas with mutant IDH1 or IDH2. Curr Opin Oncol 2012, 24:83-89.
117. Diehl F., Li M., He Y., Kinzler K.W., Vogelstein B., Dressman D. BEAMing: single-molecule PCR on microparticles in water-in-oil emulsions. Nat Methods 2006, 3:551-559.
118. Wittmann J., Jäck H.M. Serum microRNAs as powerful cancer biomarkers. Biochim Biophys Acta 2010, 1806:200-207.
119. Takeshita N., Hoshino I., Mori M., Akutsu Y., Hanari N., Yoneyama Y., et al. Serum microRNA expression profile: miR-1246 as a novel diagnostic and prognostic biomarker for oesophageal squamous cell carcinoma. Br J Cancer 2013, 2013.
120. Yoshizawa J.M., Wong D.T. Salivary microRNAs and oral cancer detection. Methods Mol Biol 2013, 936:313-324.
121. Bryant R.J., Pawlowski T., Catto J.W., Marsden G., Vessella R.L., Rhees B., et al. Changes in circulating microRNA levels associated with prostate cancer. Br J Cancer 2012, 106:768-774.
122. Gailhouste L., Gomez-Santos L., Ochiya T. Potential applications of miRNAs as diagnostic and prognostic markers in liver cancer. Front Biosci 2013, 18:199-223.
123. Chiba M., Kimura M., Asari S. Exosomes secreted from human colorectal cancer cell lines contain mRNAs, microRNAs and natural antisense RNAs, that can transfer into the human hepatoma HepG2 and lung cancer A549 cell lines. Oncol Rep 2012, 28:1551-1558.
124. Akers J.C., Ramakrishnan V., Kim R., Skog J., Nakano I., Pingle S., et al. miR-21 in the extracellular vesicles (EVs) of cerebrospinal fluid (CSF): a platform for glioblastoma biomarker development. PLoS ONE 2013, 8(10):e78115.
125. Teplyuk N.M., Mollenhauer B., Gabriely G., Giese A., Kim E., Smolsky M., et al. MicroRNAs in cerebrospinal fluid identify glioblastoma and metastatic brain cancers and reflect disease activity. Neuro Oncol 2012, 14:689-700.
126. Russo F., Di Bella S., Nigita G., Macca V., Laganà A., Giugno R., et al. miRandola: extracellular circulating microRNAs database. PLoS ONE 2012, 7:e47786.
127. Mathivanan S., Simpson R.J. ExoCarta: a compendium of exosomal proteins and RNA. Proteomics 2009, 9:4997-5000.
128. Bobrie A., Krumeich S., Reyal F., Recchi C., Moita L.F., Seabra M.C., et al. Rab27a supports exosome-dependent and -independent mechanisms that modify the tumor microenvironment and can promote tumor progression. Cancer Res 2012, 72:4920-4930.
129. Marleau A.M., Chen C.S., Joyce J.A., Tullis R.H. Exosome removal as a therapeutic adjuvant in cancer. J Transl Med 2012, 10:134.
130. Alvarez-Erviti L., Seow Y., Yin H., Betts C., Lakhal S., Wood M.J. Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes. Nat Biotechnol 2011, 29:341-345.
131. Mizrak A., Bolukbasi M.F., Ozdener G.B., Brenner G.J., Madlener S., Erkan E.P., et al. Genetically engineered microvesicles carrying suicide mRNA/protein inhibit schwannoma tumor growth. Mol Ther 2013, 21:101-108.
132. Ohno S., Takanashi M., Sudo K., Ueda S., Ishikawa A., Matsuyama N., et al. Systemically injected exosomes targeted to EGFR deliver antitumor microRNA to breast cancer cells. Mol Ther 2013, 21:185-191.
133. Kosaka N., Iguchi H., Yoshioka Y., Hagiwara K., Takeshita F., Ochiya T. Competitive interactions of cancer cells and normal cells via secretory microRNAs. J Biol Chem 2012, 287:1397-1405.
134. Gould S.J., Booth A.M., Hildreth J.E. The Trojan exosome hypothesis. Proc Natl Acad Sci U S A 2003, 100:10592-10597.
135. Breckpot K., Emeagi P.U., Thielemans K. Lentiviral vectors for anti-tumor immunotherapy. Curr Gene Ther 2008, 8:438-448.
136. Temchura V.V., Tenbusch M., Nchinda G., Nabi G., Tippler B., Zelenyuk M., et al. Enhancement of immunostimulatory properties of exosomal vaccines by incorporation of fusion-competent G protein of vesicular stomatitis virus. Vaccine 2008, 26:3662-3672.
137. Fang Y., Wu N., Gan X., Yan W., Morrell J.C., Gould S.J. Higher-order oligomerization targets plasma membrane proteins and HIV gag to exosomes. PLoS Biol 2007, 5:e158.
138. El Andaloussi S., Mäger I., Breakefield X.O., Wood M.J. Extracellular vesicles: biology and emerging therapeutic opportunities. Nat Rev Drug Discov 2013, 12:347-357.
139. Kosaka N., Takeshita F., Yoshioka Y., Hagiwara K., Katsuda T., Ono M., et al. Exosomal tumor-suppressive microRNAs as novel cancer therapy: exocure is another choice for cancer treatment. Adv Drug Deliv Rev 2013, 65:376-382.
140. Seow Y., Wood M.J. Biological gene delivery vehicles: beyond viral vectors. Mol Ther 2009, 17:767-777.
141. Mobergslien A., Sioud M. Exosome-derived miRNAs and cellular miRNAs activate innate immunity. J Innate Immum 2014, 6:105-110.
142. Koppers-Lalic D., Hogenboom M.M., Middeldorp J.M., Pegtel D.M. Virus-modified exosomes for targeted RNA delivery; a new approach in nanomedicine. Adv Drug Deliv Rev 2013, 65:348-356.
143. Batagov A.O., Kurochkin I.V. Exosomes secreted by human cells transport largely mRNA fragments that are enriched in the 3'-untranslated regions. Biol Direct 2013, 8:12.
144. Tanaka Y., Kamohara H., Kinoshita K., Kurashige J., Ishimoto T., Iwatsuki M., et al. Clinical impact of serum exosomal microRNA-21 as a clinical biomarker in human esophageal squamous cell carcinoma. Cancer 2013, 119:1159-1167.
145. Miller I.V., Raposo G., Welsch U., Prazeres da Costa O., Thiel U., Lebar M., et al. First identification of Ewing's sarcoma-derived extracellular vesicles and exploration of their biological and potential diagnostic implications. Biol Cell 2013, 105:289-303.
146. Khan S., Jutzy J.M., Valenzuela M.M., Turay D., Aspe J.R., Ashok A., et al. Plasma-derived exosomal survivin, a plausible biomarker for early detection of prostate cancer. PLoS ONE 2012, 7:e46737.
147. Lau C., Kim Y., Chia D., Spielmann N., Eibl G., Elashoff D., et al. Role of pancreatic cancer-derived exosomes in salivary biomarker development. J Biol Chem 2013, 288:26888-26897.